In Section A, contributors will obtain diverse doses and schedules of oral ABBV-744 pill to determine safe dosing regimen. More contributors is going to be enrolled within the identified monotherapy dosign routine. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section https://abbv-744-safety-and-side02356.shoutmyblog.com/31367291/abbv-744-in-combination-with-immunotherapy-an-overview